---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-038060"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-22T23:46:44.671878+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma Q1 net loss narrows 68% to $944K; eyes AI agriculture in Taiwan

## Summary
- Net loss per share improved to $(0.06) from $(0.29) in Q1 2024.
- Total operating expenses reduced 76% to $693,005.
- Net loss attributable to ABVC was $842,075, down from $2.83M.
- Recognized a land asset in Taiwan valued at $7.67M for potential AI-integrated GAP-compliant plant factory.
- Company evaluating development of AI-driven agricultural facility for sustainable botanical supply chain.

## SEC filing metadata
- accession: 0001213900-25-038060
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390025038060/0001213900-25-038060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025038060/ea0240063-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-038060
- JSON: https://secwatch.observer/filing/0001213900-25-038060.json
- Plain text: https://secwatch.observer/filing/0001213900-25-038060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.